Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido [2, 3-d] pyrimidine derivatives targeting epidermal growth factor receptor

J Hou, S Wan, G Wang, T Zhang, Z Li, Y Tian… - European Journal of …, 2016 - Elsevier
Three series of novel quinazoline and pyrido [2, 3-d] pyrimidine derivatives were designed,
synthesized and evaluated for their ability to inhibit EGFR tyrosine kinase and a panel of five …

Synthesis, biological evaluation and molecular docking studies of novel pyrrolo [2, 3-d] pyrimidin-2-amine derivatives as EGFR inhibitors

G Sivaiah, R Raveesha, SBB Prasad, KY Kumar… - Journal of Molecular …, 2023 - Elsevier
In the present investigation, we employed pyrrolo [2, 3-d] pyrimidine, potassium amide, and
liquid ammonia to synthesize pyrrolo [2, 3-d] pyrimidin-2-amine derivatives (4a-n) …

Synthesis and biological evaluation of novel [1, 2, 3] triazolo-pyrrolo [1, 2-a] pyrido [4, 3-d] pyrimidines as EGFR targeting anticancer agents

SR Bandi, N Kavitha, SK Nukala… - Journal of Molecular …, 2023 - Elsevier
Herein, we synthesized some new fused [1, 2, 3] triazolo-pyrrolo [1, 2-a] pyrido [4, 3-d]
pyrimidines via click chemistry followed by carbon-carbon bond coupling as key approach …

Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo [3, 4-d] Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell …

FF Sherbiny, AH Bayoumi, AM El-Morsy, M Sobhy… - Bioorganic …, 2021 - Elsevier
A series of novel hybrid pyrazolo [3, 4-d] pyramidine derivatives was designed and
chemically synthesized in useful yields. The synthesized compounds were structurally …

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-tetrahydroquinoline as potential …

Y OuYang, W Zou, L Peng, Z Yang, Q Tang… - European Journal of …, 2018 - Elsevier
Eight series of quinazoline derivatives bearing 2, 3-dihydro-indole or 1, 2, 3, 4-
tetrahydroquinoline were designed, synthesized and evaluated for the IC 50 values against …

In vitro cytotoxicity and docking study of novel symmetric and asymmetric dihydropyridines and pyridines as EGFR tyrosine kinase inhibitors

B Mansour, WA Bayoumi, MA El‐Sayed… - Chemical biology & …, 2022 - Wiley Online Library
Quinolines have a weighty effect as anticancer agents and 1, 4‐DHPs have demonstrated
efficacy as anticancer agents in several studies, as well. New hybrid models of symmetric …

Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3, 6-dimethyl-1-phenyl-4-(substituted-methoxy) pyrazolo [3, 4-d] pyrimidine Derivatives

RB Bakr, A BM Mehany… - Anti-Cancer Agents in …, 2017 - ingentaconnect.com
Background: Several pyrazolo [3, 4-d] pyrimidine derivatives have been reported as anti-
cancer agents via acting as EGFR inhibitors, mammalian target of rapamycin (mTOR) …

6, 7-Dimorpholinoalkoxy quinazoline derivatives as potent EGFR inhibitors with enhanced antiproliferative activities against tumor cells

Y Zhang, L Chen, H Xu, X Li, L Zhao, W Wang… - European Journal of …, 2018 - Elsevier
Abstract A series of novel 6, 7-dimorpholinoalkoxy quinazoline derivatives was designed,
synthesized and evaluated as potent EGFR inhibitors. Most of synthesized derivatives …

Hybrid quinazoline 1, 3, 5‐triazines as epidermal growth factor receptor (EGFR) inhibitors with anticancer activity: design, synthesis, and computational study

P Pathak, H Rimac, M Grishina, A Verma… - …, 2021 - Wiley Online Library
We report a series of hybrid quinazoline‐1, 3, 5‐triazine derivatives as EGFR inhibitors,
which were synthesised and tested by using a variety of in vitro, in silico, and in vivo …

Identification and exploration of quinazoline-1, 2, 3-triazole inhibitors targeting EGFR in lung cancer

S Kumar, S Sengupta, I Ali, MK Gupta… - Journal of …, 2023 - Taylor & Francis
Epidermal growth factor receptor (EGFR) enhances lung cancer development, due to their
inability to permeate the cell membrane, secreted growth factors work through specialized …